Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
13.97    0.45 (3.33%)
Bid:
13.75
Ask:
13.97
Spread: 0.22 (1.60%)
Market Cap: £203.67m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

Drilling Report

9 Jan 2007 08:40

Pantheon Resources PLC09 January 2007 January 9, 2007 PANTHEON RESOURCES PLC Kant #1 Well Non-commercial The Board of Pantheon Resources plc ("Pantheon") announces that it has beeninformed by the operator, Everest Resource Company ("Everest"), that the Kant #1well reached a total depth ("TD) of 4,750 feet on January 6, 2007. A full suiteof electric logs was run. The results of the log interpretation indicated thepresence of hydrocarbons in the primary objective. However the well was deemednon-commercial due to low natural gas saturation and thin reservoir sands. Adecision was to plug and abandon ("P&A") the well as non-commercial. Pantheon plans to drill another exploration well, Baptist, in first quarter2007. A further three wells in and around the company's discoveries arecurrently scheduled for 2007. As these are not subject to the farm-in terms,they would have a higher value to Pantheon, if successful. Since its initial farm-into three projects in June 2006, Pantheon has farmedinto three more prospects and drilled four wells on Project Wharton. Pantheon isnow producing from two natural gas fields, Zebu and Mohawk. A third, Caddo, isscheduled to be commissioned shortly. When combined together, these fields willmake up an attractive and growing income stream for the company. This increasingnatural gas production occurs at a time of improved US natural gas prices. Itrepresents an important income stream for a small company such as Pantheon withattractive near term financial returns. The current interests and status of all prospects in which Pantheon has aninterest are shown in table 1 Table 1: Project Wharton and Pantheon's Interests Prospect Pantheon Working Interest Status Zebu #1 9.375% ProducingCaddo #1 18.75% Due on-stream early 2007Dakota #1 18.75% P&A non-commercial showsMohawk #1 18.75% ProducingBaptist #1 11.50% Drilling scheduled for 1Q 2007Kant #1 18.75% P&A non-commercial shows Source: Everest Resource Company Project Wharton provides Pantheon with low risk plays to balance the higher risk/reward plays at the PI Project Area. Overall exploration risk for the ProjectWharton prospects is regarded as low, ranging from 50% to 80%. This compareswith 15% to 36% for the deep JV of the PI Project Area. In accordance with the AIM Rules, the information in this report has beenreviewed and signed off by Mr Robert Rosenthal, (BSc Geology, MSc Geology),Technical Director at Pantheon Resources Plc, who has over 30 years relevantexperience within the sector.Contacts: Pantheon Resources Plc Sue Graham, Chairman +44 20 7379 0118Oriel Securities LimitedScott Richardson Brown +44 20 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update
16th Mar 20232:08 pmRNSUpcoming Webinar – Registration Details
13th Mar 20233:33 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
9th Mar 202312:17 pmRNSAppointment of Independent Non-Executive Director
6th Mar 20237:00 amRNSOperational and corporate update
21st Feb 20236:06 pmRNSAnnual General Meeting & Webinar
21st Feb 20237:00 amRNSOperational update, PDMR & Issue of Equity
16th Feb 20237:00 amRNSAlkaid #2 update – well cleanout completed
10th Feb 20237:00 amRNSAlkaid #2 update
24th Jan 20231:49 pmRNSAlkaid #2 webinar and update
23rd Jan 20237:00 amRNSUpcoming Webinar - Registration Details
13th Jan 202311:03 amRNSConfirmation of Upcoming Webinar
3rd Jan 20237:00 amRNSInvestor Q&A
30th Dec 20227:00 amRNSOperational update
30th Dec 20227:00 amRNSFinal Results for the Year Ended 30 June 2022
14th Dec 20225:00 pmRNSQuarterly Repayment of Unsecured Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.